{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T08:52:20Z","timestamp":1771577540485,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019444","name":"Key Technology Innovation Special of Key Industries of the Chongqing Science and Technology Bureau","doi-asserted-by":"publisher","award":["csct2022ycjhbgzxm0034"],"award-info":[{"award-number":["csct2022ycjhbgzxm0034"]}],"id":[{"id":"10.13039\/501100019444","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018628","name":"Scientific Research Foundation of Education Department of Anhui Province of China","doi-asserted-by":"publisher","award":["2024J0330"],"award-info":[{"award-number":["2024J0330"]}],"id":[{"id":"10.13039\/501100018628","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003996","name":"Kunming Medical University","doi-asserted-by":"publisher","award":["KMMU20241239"],"award-info":[{"award-number":["KMMU20241239"]}],"id":[{"id":"10.13039\/501100003996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bbrc.2025.152064","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T12:00:40Z","timestamp":1747828840000},"page":"152064","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["IRF2-driven upregulation of OAS3 promotes AML cell proliferation by modulating the JAK-STAT signaling pathway"],"prefix":"10.1016","volume":"772","author":[{"given":"Xi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haitao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beizhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.152064_bib1","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1406184","article-title":"Acute myeloid leukemia","volume":"373","author":"D\u00f6hner","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2025.152064_bib2","article-title":"Advances in acute myeloid leukemia","volume":"375","author":"Newell","year":"2021","journal-title":"BMJ"},{"issue":"2024","key":"10.1016\/j.bbrc.2025.152064_bib3","first-page":"12","article-title":"Cancer statistics","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbrc.2025.152064_bib4","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1182\/blood-2011-12-379008","article-title":"Acute myeloid leukemia in the real world: why population-based registries are needed","volume":"119","author":"Juliusson","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2025.152064_bib5","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1002\/cncr.33458","article-title":"De novo acute myeloid leukemia: a population-based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database, 1980 to 2017","volume":"127","author":"Sasaki","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.bbrc.2025.152064_bib6","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1182\/blood-2010-03-276485","article-title":"Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia","volume":"116","author":"Kantarjian","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2025.152064_bib7","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1182\/blood.2021011103","article-title":"Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapy","volume":"138","author":"Itzykson","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2025.152064_bib8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1089\/jir.2010.0107","article-title":"The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities","volume":"31","author":"Kristiansen","year":"2011","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.bbrc.2025.152064_bib9","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1089\/10799900260286696","article-title":"Genomic structure of the mouse 2',5'-oligoadenylate synthetase gene family","volume":"22","author":"Kakuta","year":"2002","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.bbrc.2025.152064_bib10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3390\/genes14020527","article-title":"Genetic ethnic differences in human 2'-5'-Oligoadenylate synthetase and disease associations: a systematic review","volume":"14","author":"Gokul","year":"2023","journal-title":"Genes"},{"key":"10.1016\/j.bbrc.2025.152064_bib11","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.biochi.2007.02.003","article-title":"The human 2'-5'oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2'-5' instead of 3'-5' phosphodiester bond formation","volume":"89","author":"Hovanessian","year":"2007","journal-title":"Biochimie"},{"key":"10.1016\/j.bbrc.2025.152064_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1534","article-title":"RNA regulation of the antiviral protein 2'-5'-oligoadenylate synthetase","volume":"10","author":"Schwartz","year":"2019","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"10.1016\/j.bbrc.2025.152064_bib13","doi-asserted-by":"crossref","first-page":"18490","DOI":"10.1073\/pnas.0809242105","article-title":"An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer","volume":"105","author":"Weichselbaum","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2025.152064_bib14","doi-asserted-by":"crossref","first-page":"815480","DOI":"10.3389\/fcell.2022.815480","article-title":"OAS3 is a Co-Immune biomarker associated with tumour microenvironment, disease staging, prognosis, and treatment response in multiple cancer types","volume":"10","author":"Li","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbrc.2025.152064_bib15","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2174\/156652306778520683","article-title":"The role of IRF1 and IRF2 transcription factors in leukaemogenesis","volume":"6","author":"Choo","year":"2006","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.bbrc.2025.152064_bib16","doi-asserted-by":"crossref","DOI":"10.4274\/tjh.galenos.2024.2025.0292","article-title":"The IRF2-INPP4B pathway is activated in CD4+ T cells and aggravates acute myeloid leukemia development by inhibiting apoptosis","author":"Xing","year":"2025","journal-title":"Turk. J. Haematol."},{"key":"10.1016\/j.bbrc.2025.152064_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40659-019-0218-7","article-title":"IRF2-INPP4B-mediated autophagy suppresses apoptosis in acute myeloid leukemia cells","volume":"52","author":"Zhang","year":"2019","journal-title":"Biol. Res."},{"key":"10.1016\/j.bbrc.2025.152064_bib18","doi-asserted-by":"crossref","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","article-title":"LinkedOmics: analyzing multi-omics data within and across 32 cancer types","volume":"46","author":"Vasaikar","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2025.152064_bib19","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1002\/imt2.36","article-title":"Sangerbox: a comprehensive, interaction-friendly clinical bioinformatics analysis platform","volume":"1","author":"Shen","year":"2022","journal-title":"Imeta"},{"key":"10.1016\/j.bbrc.2025.152064_bib20","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.bbrc.2025.152064_bib21","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1101\/gr.6.10.986","article-title":"Real time quantitative PCR","volume":"6","author":"Heid","year":"1996","journal-title":"Genome Res."},{"key":"10.1016\/j.bbrc.2025.152064_bib22","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/ajh.26917","article-title":"Relationship between comorbidities, mutational profile, and outcome after intensive chemotherapy in patients older than 60 years with acute myeloid leukemia: assessment of different risk scores","volume":"98","author":"Bachelot","year":"2023","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bbrc.2025.152064_bib23","doi-asserted-by":"crossref","first-page":"1017194","DOI":"10.3389\/fonc.2022.1017194","article-title":"Survival, response rates, and post-transplant outcomes in patients with acute myeloid Leukemia aged 60-75 treated with high intensity chemotherapy vs. lower intensity targeted therapy","volume":"12","author":"Sahasrabudhe","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrc.2025.152064_bib24","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/ajh.26991","article-title":"Real-world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemia","volume":"98","author":"Matthews","year":"2023","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bbrc.2025.152064_bib25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.annonc.2022.11.004","article-title":"Moving toward individualized target-based therapies in acute myeloid leukemia","volume":"34","author":"Bazinet","year":"2023","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbrc.2025.152064_bib26","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1186\/s12885-020-07034-6","article-title":"Prognostic characterization of OAS1\/OAS2\/OAS3\/OASL in breast cancer","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbrc.2025.152064_bib27","doi-asserted-by":"crossref","first-page":"610350","DOI":"10.3389\/fgene.2020.610350","article-title":"Construction of an RNA-binding protein-related prognostic model for pancreatic adenocarcinoma based on TCGA and GTEx databases","volume":"11","author":"Wen","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.bbrc.2025.152064_bib28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00262-024-03898-w","article-title":"Targeting OAS3 for reversing M2d infiltration and restoring anti-tumor immunity in pancreatic cancer","volume":"74","author":"Zhang","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bbrc.2025.152064_bib29","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1002\/hed.27803","article-title":"Bioinformatics approach combined with experimental verification reveals OAS3 gene implicated in paclitaxel resistance in head and neck cancer","volume":"46","author":"Caglar","year":"2024","journal-title":"Head Neck"},{"key":"10.1016\/j.bbrc.2025.152064_bib30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/imm.12560","article-title":"Extracellular 2'5'-oligoadenylate synthetase 2 mediates T-cell receptor CD3-\u03b6 chain down-regulation via caspase-3 activation in oral cancer","volume":"147","author":"Dar","year":"2016","journal-title":"Immunology"},{"key":"10.1016\/j.bbrc.2025.152064_bib31","doi-asserted-by":"crossref","first-page":"6684","DOI":"10.1093\/nar\/gkl968","article-title":"Selection and cloning of poly(rC)-binding protein 2 and Raf kinase inhibitor protein RNA activators of 2',5'-oligoadenylate synthetase from prostate cancer cells","volume":"34","author":"Molinaro","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2025.152064_bib32","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.21037\/tcr-22-698","article-title":"Development of multivariable risk signature based on four immune-related RNA-binding proteins to predict survival and immune status in lung adenocarcinoma","volume":"11","author":"You","year":"2022","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.bbrc.2025.152064_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215583","article-title":"TKI resistant-based prognostic immune related gene signature in LUAD, in which FSCN1 contributes to tumor progression","volume":"532","author":"Shi","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2025.152064_bib34","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005320","article-title":"Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy","volume":"10","author":"Casarrubios","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbrc.2025.152064_bib35","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12957-018-1475-6","article-title":"Prediction of key genes and pathways involved in trastuzumab-resistant gastric cancer","volume":"16","author":"Yu","year":"2018","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.bbrc.2025.152064_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0268967","article-title":"Integrated bioinformatics and statistical approaches to explore molecular biomarkers for breast cancer diagnosis, prognosis and therapies","volume":"17","author":"Alam","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2025.152064_bib37","doi-asserted-by":"crossref","first-page":"9089397","DOI":"10.1155\/2022\/9089397","article-title":"Identification of significant secreted or membrane-located proteins in laryngeal squamous cell carcinoma","volume":"2022","author":"Yan","year":"2022","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.bbrc.2025.152064_bib38","doi-asserted-by":"crossref","first-page":"681","DOI":"10.4149\/neo_2018_181020N786","article-title":"Identification of key pathways and genes changes in pancreatic cancer cells (BXPC-3) after cross-talk with primary pancreatic stellate cells using bioinformatics analysis","volume":"66","author":"Tang","year":"2019","journal-title":"Neoplasma"},{"key":"10.1016\/j.bbrc.2025.152064_bib39","first-page":"3236","article-title":"Identification and characterization of biomarkers and their functions for docetaxel-resistant prostate cancer cells","volume":"18","author":"Deng","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbrc.2025.152064_bib40","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1158\/0008-5472.CAN-06-4250","article-title":"Gene expression profiling of breast, prostate, and glioma cells following single versus fractionated doses of radiation","volume":"67","author":"Tsai","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2025.152064_bib41","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/leu.2014.311","article-title":"Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk","volume":"29","author":"Sava","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.bbrc.2025.152064_bib42","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202201582R","article-title":"OASL knockdown inhibits the progression of stomach adenocarcinoma by regulating the mTORC1 signaling pathway","volume":"37","author":"Zhao","year":"2023","journal-title":"FASEB J."},{"key":"10.1016\/j.bbrc.2025.152064_bib43","first-page":"757","article-title":"Corylin sensitizes breast cancer cells to overcome tamoxifen resistance by regulating OAS1\/miR-22-3p\/SIRT1 axis","volume":"68","author":"Che","year":"2021","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.bbrc.2025.152064_bib44","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.leukres.2005.01.015","article-title":"JAK-STAT signaling involved in phorbol 12-myristate 13-acetate- and dimethyl sulfoxide-induced 2'-5' oligoadenylate synthetase expression in human HL-60 leukemia cells","volume":"29","author":"Cohen","year":"2005","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bbrc.2025.152064_bib45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12943-023-01929-1","article-title":"JAK\/STAT in leukemia: a clinical update","volume":"23","author":"Liang","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrc.2025.152064_bib46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.apsb.2020.07.010","article-title":"Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies","volume":"11","author":"Song","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bbrc.2025.152064_bib47","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/j.immuni.2022.10.020","article-title":"The transcription factor IRF2 drives interferon-mediated CD8(+) T cell exhaustion to restrict anti-tumor immunity","volume":"55","author":"Lukhele","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.bbrc.2025.152064_bib48","doi-asserted-by":"crossref","first-page":"482","DOI":"10.5483\/BMBRep.2021.54.9.070","article-title":"IRF2 enhances RANKL-induced osteoclast differentiation via regulating NF-\u03baB\/NFATc1 signaling","volume":"54","author":"Kim","year":"2021","journal-title":"BMB Rep."},{"key":"10.1016\/j.bbrc.2025.152064_bib49","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.immuni.2022.11.010","article-title":"IRF2 integrates inflammatory signals to balance T cell exhaustion","volume":"55","author":"Sheikh","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.bbrc.2025.152064_bib50","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/ajh.1144","article-title":"Alterations in IRF1\/IRF2 expression in acute myelogenous leukemia","volume":"68","author":"Preisler","year":"2001","journal-title":"Am. J. Hematol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25007788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25007788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:53:40Z","timestamp":1762095220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25007788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":50,"alternative-id":["S0006291X25007788"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152064","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IRF2-driven upregulation of OAS3 promotes AML cell proliferation by modulating the JAK-STAT signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152064"}}